Hospitals Deny Admission: Four doctors under Delhi Govt scanner after 47-year-old man succumbs to injuries

New Delhi: Following allegations that an accused patient succumbed to his injuries after being denied treatment at four government hospitals, the state health department has advised implementing disciplinary actions and issuing suspensions to the four doctors associated with Guru Tegh Bahadur (GTB) Hospital and Lok Nayak Hospital in connection with the case. 

The four doctors have been recommended for suspension after it was found that they allegedly denied treatment to the patient, even though there were beds available at the hospitals.

According to a senior health department official, the recommendation of the four doctors from the two hospitals will be sent to the National Capital Civil Services Authority (NCCSA) for further approval. Upon approval, appropriate action will be taken against the doctors.

Also read- Denied Treatment At 3 Govt Hospitals: Delhi Man Succumbs To Injuries, Health Minister Seeks Explanation

NCCSA is an administrative authority that manages the Civil Services in Delhi. The authority is a three-member committee including- the Chief Minister of Delhi, the Chief Secretary and the Principal Home Secretary.

As per an Indian Express news report, the incident has prompted the health department to take swift action against the management of the two hospitals. Censuring the hospitals, the department has directed the Chief Medical Officers (CMOs) concerned to submit a detailed report on the matter. 

The report is expected to include information on when the patient arrived at the hospital, the attending doctor, the patient’s wait for treatment, CCTV footage, and the doctor allegedly responsible for denying treatment and admission.

Medical Dialogues team recently reported that the Delhi Health Minister Saurabh Bharadwaj on Wednesday said the city government asked for an explanation from three state-run hospitals regarding the allegations that he could have saved had the Dilli Ke Farishte scheme been functional. A 47-year-old man died of injuries he suffered after jumping out of a moving police van early on Wednesday, a senior officer said.

Pramod was arrested after a 21-year-old woman alleged that he had molested her in an inebriated state and was taken to four government hospitals by the police personnel due to the unavailability of beds or equipment at the facilities, he added.

The minister said that if the ‘Farishte Dilli Ke’ scheme had been fully functional, the man could have been taken to a nearby private hospital having the requisite medical services and there would have been fair chances of him surviving.

The patient was allegedly refused admission by three Delhi government hospitals namely GTB Hospital, JPC Hospital and Lok Nayak Hospital and one central government hospital, namely RML Hospital.

In addition, the health department also plans to escalate the issue further by informing the Delhi Medical Council (DMC) about the incident.

“The patient was first taken to JPC hospital where he was intubated and sent to GTB…GTB Hospital then sent him to LNJP….One of the hospitals refused to give the patient even a stretcher to lie on while waiting for a doctor. This is a basic facility one hospital has to provide in emergency cases…We also got information that the hospitals had vacant beds and despite that, they refused to admit the patient…Be it an accused or any other person, a hospital should provide treatment to people from any background…” said the source of the Daily. 

Also read- Patient Dies Due To Lack Of Oxygen: NHRC Directs Bihar Govt To Submit Report In Four Weeks

Powered by WPeMatico

Medical Bulletin 6/January/2024

Here are the top medical news of the day:

Even in midlife, disrupted sleep tied to memory, thinking problems later on

People who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later, according to new research published in the January 3, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology. The study does not prove that sleep quality causes cognitive decline. It only shows an association.

“Given that signs of Alzheimer’s disease start to accumulate in the brain several decades before symptoms begin, understanding the connection between sleep and cognition earlier in life is critical for understanding the role of sleep problems as a risk factor for the disease,” said study author Yue Leng, PhD, of the University of California, San Francisco. “Our findings indicate that the quality rather than the quantity of sleep matters most for cognitive health in middle age.”

The study involved 526 people with an average age of 40. They were followed for 11 years.

Reference: Even in midlife, disrupted sleep tied to memory, thinking problems later on; AMERICAN ACADEMY OF NEUROLOGY; Neurology

Is radon linked to health condition other than lung cancer?

Radon, a naturally occurring radioactive gas produced when metals like uranium or radium break down in rocks and soil, is a known cause of lung cancer. Now new research has found exposure to high levels of this indoor air pollutant is associated with an increased risk of another condition in middle age to older female participants with ischemic stroke. The study is published in the January 3, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology. Ischemic stroke is caused by a blockage of blood flow to the brain and is the most common type of stroke.

The condition, called clonal hematopoiesis of indeterminate potential (CHIP), develops when some hematopoietic stem cells, the building blocks for all blood cells, undergo genetic mutations as a person ages. Cells with such mutations replicate more quickly than cells without them. Previous research has shown people with CHIP may have a higher risk of blood cancers like leukemia and cardiovascular disease including stroke.

The study involved 10,799 female participants with an average age of 67. Approximately half of participants had a stroke or blood clots.

Reference: Is radon linked to health condition other than lung cancer?; AMERICAN ACADEMY OF NEUROLOGY

Using the body’s own cells to treat traumatic brain injury

More than a million people in the US suffer from a traumatic brain injury (TBI) every year, about 230,000 of them are hospitalized, and almost 70,000 die from TBI-related causes. There is currently no treatment for the damage caused to brain tissue during a TBI, beyond managing a patient’s symptoms. One of the main drivers of TBI-caused damage is a runaway inflammatory cascade in the brain.

Scientists have created a new treatment for traumatic brain injury (TBI) that shrank brain lesions by 56% and significantly reduced local inflammation levels in pigs. The new approach leverages macrophages, a type of white blood cell that can dial inflammation up or down in the body in response to infection and injury.

Reference: Using the body’s own cells to treat traumatic brain injury; PNAS Nexus

Powered by WPeMatico

FMGE December 2023 Exam To Be held On 20th January, Details

Delhi: The Foreign Medical Graduate Examination (FMGE) December 2023 exam is going to be conducted on 20th January 2024. The result is expected to be declared by 20th February 2024.

In the month of November 2023, the National Board of Examinations (NBE) released the detailed schedule for FMGE. It shall be conducted at various exam centres engaged for the purpose. Only eligible candidates will be allowed to appear in the FMGE who have both the Eligibility Certificate (if applicable) and the Provisional Pass Certificate/Degree Certificate of Primary Medical Qualification.

Candidates who fail to submit the documents as prescribed in the Information Bulletin for FMGE will not be allowed to appear in the examination and will be declared ineligible to appear.

Admit Cards for the FMG Examination shall be available to download at the NBEMS website from 12th January 2024 onwards. Candidates found ineligible before the conduct of the examination shall not be issued admit cards. Candidates will be informed through SMS/Email alerts and website notices regarding the availability of the admit card on the NBEMS website. Admit cards will not be sent to the candidates by Post/Email.

Candidates are required to download their admit card from the NBEMS website and affix firmly their recent (not more than 3 months old) passport-size photograph in the space provided on the admit card.

Exam pattern –

The examination consists of one paper comprising 300 multiple-choice questions. Each question shall have 4 response options/distractors in English language only. Candidates are required to select the correct/best/most appropriate response/answer out of the 4 response options provided in each question. FMGE is divided into two parts of 150 questions, each with a time allocation of 150 minutes for each part. There is a scheduled break between the two parts.

The examination shall be a multiple-choice questions (MCQs) test delivered using a computer network as per the prescribed scheme. Negative Marking: There shall be no negative marking.

A candidate shall be declared as having passed only if he/she obtains a minimum of 150 marks out of 300 in the examination. Results (Pass/Fail) for eligible candidates will be displayed on the NBEMS website. There is no provision for re-totaling/reevaluation.

A demo test shall be available for the benefit of candidates to familiarise themselves with the Computer Based Test format on the website of NTA. Candidates will be able to access the Demo test tentatively from 10th January 2024 onwards.

The
following schedule will be followed on the exam day –

Activities

Part – I

(9:00 AM
– 11:30 AM)

Part – II

(2:00 PM
– 04:30 PM)

Allow
Candidates to enter the examination centre and Commence Registration

07:00 AM

12:00 PM

Entry
closes at the Examination Center

08:30 AM

01:30 PM

Grant
access for Candidate Login

08:45 AM

01:45 PM

Candidates
log in to read instructions

08:50 AM

01:50 PM

Exam
Start Time

09:00 AM

02:00 PM

Powered by WPeMatico

Lilly launches end to end digital healthcare experience through LillyDirect

Indianapolis: Eli Lilly and Company has announced LillyDirect, a new digital healthcare experience for patients in the U.S. living with obesity, migraine and diabetes. LillyDirect offers disease management resources, including access to independent healthcare providers, tailored support, and direct home delivery of select Lilly medicines through third-party pharmacy dispensing services.

“A complex U.S. healthcare system adds to the burdens patients face when managing a chronic disease. With LillyDirect, our goal is to relieve some of those burdens by simplifying the patient experience to help improve outcomes,” said David A. Ricks, Lilly‘s chair and CEO. “LillyDirect offers more choices in how and where people access healthcare, including a convenient home delivery option to fill Lilly medicines they have been prescribed.”

For patients living with obesity, migraine and diabetes, LillyDirect offers:

  • LillyDirect Pharmacy Solutions, a digital pharmacy for select Lilly medicines powered by third party online pharmacy fulfillment services. LillyDirect Pharmacy Solutions gives patients a simple option to get consistent access to Lilly medicines they have been prescribed with the added convenience of home delivery. By obtaining medicines directly from Lilly, patients can easily access Lilly‘s affordability solutions and savings card opportunities are automatically applied for patients who qualify. Medicines fulfilled by pharmacy service providers through LillyDirect Pharmacy Solutions ship free of charge.
  • Disease state and healthcare educational information to help empower and support patients on their care journeys.
  • Access to independent telehealth providers that could complement a patient’s current primary care team or be an alternative to in-person care for certain conditions.
  • An independent search tool that allows a patient to find healthcare professionals near them if they prefer in-person care.

“We know that people have come to depend on the efficiency and convenience of digital solutions to meet a variety of their everyday needs – healthcare being one of them,” said Frank Cunningham, group vice president, global value and access at Lilly. “We launched LillyDirect with the hope that it will offer patients an innovative end-to-end experience to manage their health and access their medicines, so they can get back to living their lives.”

Read also: Eli Lilly concludes acquisition of POINT Biopharma

Powered by WPeMatico

NBE Grants Final Opportunity To FMGE Dec 2023 Candidates To Submit Deficient Documents, Details

Delhi : Through a recent notice, NBE (National Board of Examinations in Medical Sciences) has given final opportunity to FMGE Dec 2023 candidates to submit deficient documents.

In line with the clause 2.8.3 and 8.30.2 of the Information Bulletin for FMGE Dec 2023, the list of candidates who have failed to rectify the deficiencies related to the following documents even by 1st January 2024 is published herein below:

a. Primary Medical Qualification Degree certificate/Provisional Pass Certificate duly apostilled/attested by the Embassy of India in the country from where the primary medical qualification has been obtained

b. Eligibility Certificate issued by the NMC/MCI (If applicable)/ Admission Letter/ Proof of qualifying NEET-UG

c. Proof of Citizenship

d. Mismatch in Name/Date of Birth in documents submitted

e. Supportive documents for transfer from one medical institution to another

f. Mark sheet of standard 12th and Caste certificate (SC/ST/OBC)

Click below for the list of candidates who have failed to submit deficient documents

 https://medicaldialogues.in/pdf_upload/natboard-datapublicnoticeuploadedfilefile202401059373-229434.pdf

Final opportunity to submit the documents is being given during 05.01.2024 (12:00 PM onwards) to 08.01.2024 (till 11:55 PM)

Documents can only be submitted through the Online Deficient Document Submission Portal which can be accessed through weblink:

It is once again reiterated that pursuant to the recommendations of the National Medical Commission and approval of the Ministry of Health and Family Welfare (MoHFW), Govt. of India,only eligible candidates will be allowed to appear in the FMGE who have both the Eligibility Certificate (if applicable) and the Provisional Pass Certificate/Degree Certificate of Primary Medical Qualification.

In terms of clause 2.8.4 and 8.30.3 of the Information Bulletin for FMGE December 2023, candidates who fail to submit duly completed applications with requisite documents and/or fail to rectify the deficiencies in their applications by the last date prescribed for rectification shall be declared ineligible. Admit Card shall not be issued to candidates who are declared ineligible before the conduct of the examination.

Candidates who will fail to submit the required documents shall be declared INELIGIBLE for FMGE December 2023 session. No further opportunity to submit documents shall be given.

For any query, please contact NBEMS Candidate Care Support at 011-45593000 or write to National Board of Examinations in Medical Sciences at its Communication Web Portal 

To view the official Notice, Click here :  https://medicaldialogues.in/pdf_upload/natboard-datapublicnoticenotice202401057095-229435.pdf

Powered by WPeMatico

J&K High Court directs 45 SKIMS employees service regularization

Srinagar: In a landmark verdict, the High Court of Jammu and Kashmir and Ladakh has directed the regularization of services for employees of the Sher-e-Kashmir Institute of Medical Sciences (SKIMS) from their initial appointment date. This significant ruling comes as a relief to 45 petitioner-employees serving as Staff Nurses on a contractual basis.

Justice Chowdhary pointed out that the court has taken note of the violation of Articles 14 and 16 of the Constitution of India and stated, “It emerges from the facts of the case that two groups of similarly situated employees were considered, and one group was accorded the benefit of regularisation, whereas the petitioners were discriminated against.”

The court’s decision challenges Government Order No 15-SKIMS of 2013, which previously regularized services from the order’s issuance date (March 19, 2013). According to a report by The Daily Excelsior, the petitioner-employees successfully argued for regularization from their initial appointments under SRO 255 dated August 5, 2003, specifically against migrant vacancies. This aligns their regularization process with other contractual employees who have been granted similar treatment.

Justice M A Chowdhary nullified the contested order and decreed the regularisation of employees from the date of their initial appointment, as stipulated under SRO 255 dated August 05, 2003. Furthermore, SKIMS authorities are now mandated to extend all consequential benefits resulting from the retrospective regularisation. The court’s scrutiny revealed a failure by SKIMS authorities to delineate why contract Staff Nurses, similarly situated and engaged against migrant vacancies, had not been subjected to retrospective regularisation. This discriminatory oversight prompted the court to underscore the unjust denial of equal employment opportunities to the petitioners compared to their counterparts in public service, reports the Daily. 

The court stated that the petitioners have been discriminated against considering that SKIMS authorities have not given them the similar benefits which have been enjoyed by their counterparts, instead, the cases of these employees were deferred for unknown reasons.“The orders impugned are bad in law, in as much as regularization of services of petitioners must relate to the date of their initial appointment; that due to the delay caused in regularizing the services of the petitioners, the petitioners have suffered a lot as they were entitled to be regularized from the date they were initially appointed, however, their cases have been wilfully delayed”, read the judgment.

This court decision not only ensures justice for SKIMS employees but also sets a precedent for equitable employment practices, emphasizing the need for fair treatment and equal opportunities in the realm of public employment. The ruling stated that the petitioners were entitled to regularisation from their initial appointment and declared the contested orders to be legally invalid. 

Also Read: Dr Jitendra Singh reviews pace of work on AIIMS Jammu; issues instructions to administration and CPWD

Powered by WPeMatico

NMC tells Medical Colleges to Submit NEET SS Admission Info, Online Portal to Remain Open till 10th January

New Delhi: The Postgraduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) has asked the medical institutes to fill in the requisite NEET-SS admission data on the online portal.

Issuing a public notice in this regard, the PG Board of NMC has informed that the online portal for filling up the details of students who got admitted to the Super-Speciality courses shall remain open from 5th to 10th January 2024.

The Commission has clarified that “No physical/ manual data will be accepted whatsoever is the reason.”

Referring to the notice issued by the Medical Counselling Committee (MCC) dated 30.12.2023, NMC PG Board mentioned that the students have to report by 6.00 p.m. of 05.01.2024 after the 2 nd round of Counselling.

“Accordingly, all the Medical Colleges/ Institutes in India under the Commission are hereby informed that the online portal for filling up the details of candidates who took admission in Super Specialty Courses, shall be opened from 5th to 10th January, 2024,” NMC PGMEB mentioned in the notice.

“All are requested to fill in the requisite data in the stipulated time,” the notice mentioned, adding that the “onus of furnishing true, correct and authentic information is upon the College concerned and in case of furnishing of any wrong/incorrect information it shall be open to NMC to initiate action as is permissible in law.”

In case of any difficulty in accessing the NMC website, the colleges have been asked to send an email to support.pgmonitoring@nmc.org.in and thereafter the Commission office shall revert within 02 working days to resolve the query/issue.

Earlier, with respect to MBBS admissions, the Undergraduate Medical Education Board (UGMEB) of NMC clarified that the students who have not registered in the NMC portal shall be considered as invalid admissions and such admissions shall not be eligible for future registration processes as well.

The Apex Medical Commission had informed that only those MBBS students who have registered in the NMC portal shall be considered to be valid admissions.

Releasing the list containing the details of MBBS students admitted in this academic year, the UG Board of NMC had asked the students, who were admitted to MBBS course in the academic year 2023-2024 and whose details are not reflected in the list, to contact the Directorate of Medical Education/ Counselling Authority urgently.

To view the notice, click on the link below:

https://medicaldialogues.in/pdf_upload/neet-ss-admission-data-229431.pdf

Also Read: MBBS Admissions not uploaded on the NMC Portal will be considered INVALID

Powered by WPeMatico

Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its investigational candidates from its diverse pipeline in hematologic malignancies and solid tumors. Global Phase 3 studies have been initiated and are actively enrolling for the following investigational candidates:

  • Bomedemstat, an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor, being evaluated for the treatment of certain patients with essential thrombocythemia (ET);
  • Nemtabrutinib, an investigational oral, reversible, non-covalent Bruton’s tyrosine kinase (BTK) inhibitor, being evaluated for the treatment of certain patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL);
  • MK-2870, an investigational trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) being developed in collaboration with Kelun-Biotech, which is being evaluated for certain patients with non-small cell lung cancer (NSCLC) and certain patients with previously treated endometrial carcinoma;
  • and MK-5684, an investigational CYP11A1 inhibitor being developed in collaboration with Orion, which is being evaluated for the treatment of certain patients with metastatic castration-resistant prostate cancer (mCRPC).

Read also: USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults

“These Phase 3 trial initiations for four of our investigational candidates represent a critical step forward in our efforts to advance potential treatment options for people with solid tumors and hematologic neoplasms and malignancies,” said Dr. Marjorie Green, senior vice president and head of oncology, global clinical development, Merck Research Laboratories. “We have a proud legacy of turning breakthrough science into medicines that save and improve lives around the world, and we are dedicated to continuing research to expand our broad portfolio of oncology therapeutics to continue to address unmet needs in cancer care.”

Read also: Merck gets European Commission nod for two new indications for Keytruda in gastrointestinal cancers

Powered by WPeMatico

Bond Service allotment in Maharashtra: DMER notifies on 1140 Vacancies For PG Degree Holders, details

Maharashtra:
The Directorate of Medical Education & Research (DMER Maharashtra) has
released the vacancy details for online allotment of Government Social
responsibility service (Bond Service) to PG Degree holders.

1140 vacancies are there for online allotment of Government Social
responsibility services to PG Degree holders.

Detailed seat matrix –

Bhagwati Hosp. N. T. C. Bldg. Boriwali (W)

10

BHARATRATNA DR. BABASAHEB AMBEDKAR HOSPITAL

10

BHGMC DHULE

58

GGMC MUMBAI

29

GMC AKOLA

52

GMC BARAMAT

46

GMC CHANDRAPUR

76

GMC GONDIA

78

GMC JALGAON

83

GMC KOLHAPUR

45

GMC LATUR

26

GMC MIRAJ

43

GMC NAGPUR

33

GMC NANDURBAR

48

GMC Sindhudurg

50

GOVERNMENT MEDICAL COLLEGE, ALIBAG-RAIGAD

41

Government Medical College, Parbhani

20

Government Medical College, Ratnagiri

31

GSMC & KEM HOSPITAL

13

IGGMC NAGPUR

23

K.B.BHABHA MUNICIPAL GENERAL HOSPITAL ,BANDRA

10

KASTURBA HOSPITAL FOR INFECTION DISES

3

KHAN BAHADUR BHABHA HOSPITAL, KURLA WEST MUMBAI 70

11

Krantiveer Mahatma Jyotiba Phule Hosp., Vikhroli (E)

6

KRATNIJYOTI SAVITRIBAI PHULE HOSPITAL, BORIVALI EAST MUMBAI

7

LTMC & SION HOSPITAL

21

Maa. Hosp. Chembur

1

MANOHAR WAMANRAO DESAI MUNICIPAL GENERAL HOSPITAL

9

PT MADAN MOHAN MALAVIYA SHATABDI HOSPITAL GOVANDI MUMBAI

12

Rajawadi Hosp. Ghatkoper (E)

20

S.V.D.SAVARKAR MUNICIPAL GEN.HOSPITAL MULUND EAST

7

SANT MUKTABAI MUNCIPAL GENERAL HOSPITAL,BARVENAGAR,GHATKOPAR

7

SIDDHARTH MUNICIPAL GENERAL HOSPITAL

9

SMT. MANSADEVI TULSIDAS AGARWAL HOSPITAL

12

SRTR BEED

54

TNMC & NAIR HOSPITAL

8

V N DESAI MUNICIPAL GENERAL HOSPITAL

7

VMMC SOLAPUR

52

VNMC YAVATMAL

69

The detailed counselling schedule –

The candidates can fill out the online application form and
preferences up to 09.01.2024 up to 11.59 PM. On 10.01.2024 by evening, the
declaration of allotment of bond service to the candidate and issue of
recommendation letter web portal through login ID will be done.

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/vacancy-dated-04012024-229385.pdf

Powered by WPeMatico

Final PGMER 2023 Regulations released in Gazette

Around four months after the Draft was released, the final Post-Graduate Medical Education Regulations, 2023 (PGMER 2023) have now been published. These Regulations, which have come into force from the date of their publication in the official gazette i.e. 29.12.2023, lay down the rules and regulations regarding admission, counselling, and other details related to the postgraduate medical courses.

For more details, check out the link given below:

Final PGMER 2023 Regulations Released In Gazette, Details

Powered by WPeMatico